Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Feb 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 106270401000001119 | Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 106270501000001115 | Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Has VMP | Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Has specific active ingredient | Lidocaine hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Has specific active ingredient | Epinephrine bitartrate | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Epinephrine | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lignospan Special 20mg/ml / 12.5micrograms/ml solution for injection 1.8ml cartridges (Septodont Ltd) 50 cartridge 5 x 10 x 1.8ml cartridges | Is a | True | Lidocaine 36mg/1.8ml (2%) / Adrenaline (base) 22.5micrograms/1.8ml (1 in 80,000) solution for injection cartridges 50 cartridge | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR